Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of Leukocytes01:27

Disorders of Leukocytes

1.6K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.6K
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

7.5K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
7.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>ABCC</i> Gene Variants and Their Effects on Non-Response and Relapse in Pediatric Patients with Central Nervous System Tumors: A Cohort Study.

Current issues in molecular biology·2026
Same author

Efficacy of hydroxychloroquine with azithromycin in mild COVID-19: randomized clinical trial.

Cirugia y cirujanos·2026
Same author

Taking High-Tech to the Field: Leukemia Diagnosis in Pediatric Mexican Patients from Vulnerable and Remote Regions.

Diagnostics (Basel, Switzerland)·2026
Same author

Geographic and Socioeconomic Determinants of Treatment Abandonment in Pediatric Acute Leukemia: A Cohort Study in South-Central Mexico.

Cancer control : journal of the Moffitt Cancer Center·2026
Same author

Malnutrition at diagnosis of acute lymphoblastic leukemia negatively affects survival in children.

Boletin medico del Hospital Infantil de Mexico·2025
Same author

MicroRNA Profiling Identifies Diagnostic and Prognostic Markers in Pediatric Sarcoma.

Cancers·2025

Related Experiment Video

Updated: Nov 30, 2025

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

22.1K

Aberrant immunophenotypes in acute lymphoblastic leukemia.

Miguel E Cuéllar-Mendoza1, Francisco R Chávez-Sánchez1, Elisa Dorantes-Acosta2

  • 1Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico.

Boletin Medico Del Hospital Infantil De Mexico
|November 13, 2020
PubMed
Summary

Aberrant immunophenotypes in acute lymphoblastic leukemia (ALL) are distinct antigen expression patterns. These patterns aid in classifying leukemia and serve as prognostic factors and residual disease markers.

Keywords:
HematologicHematologíaImmunophenotypesInmunofenotiposLeucemiaLeukemiaLinfoblásticaLymphoblasticReviewRevisión

More Related Videos

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.4K
Isolation of Precursor B-cell Subsets from Umbilical Cord Blood
14:06

Isolation of Precursor B-cell Subsets from Umbilical Cord Blood

Published on: April 16, 2013

18.5K

Related Experiment Videos

Last Updated: Nov 30, 2025

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

22.1K
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.4K
Isolation of Precursor B-cell Subsets from Umbilical Cord Blood
14:06

Isolation of Precursor B-cell Subsets from Umbilical Cord Blood

Published on: April 16, 2013

18.5K

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • Acute lymphoblastic leukemia (ALL) is a common blood cancer.
  • Immunophenotyping is crucial for leukemia classification.
  • Aberrant immunophenotypes present unique antigen expression patterns.

Purpose of the Study:

  • To review the definition, epidemiology, and uses of aberrant immunophenotypes in ALL.
  • To highlight the role of aberrant immunophenotypes in leukemia classification.
  • To discuss their significance as prognostic factors and residual disease markers.

Main Methods:

  • Analysis of immunophenotypic characteristics in neoplastic cells.
  • Utilizing cell flow cytometry and immunohistochemistry with antibodies.
  • Reviewing existing literature on aberrant immunophenotypes.

Main Results:

  • Aberrant immunophenotypes differ from normal hematopoietic maturation.
  • Examples include myeloid antigens or asynchronous antigen expression in ALL.
  • These findings are studied for prognostic value and disease monitoring.

Conclusions:

  • Aberrant immunophenotypes are key diagnostic and prognostic indicators in ALL.
  • Understanding these patterns improves leukemia classification and management.
  • Further research into their epidemiology and applications is warranted.